Tough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
[grabpress_video guid=be7264b80c1157e29a2054d1973e1f91fbe14cb3 embed_id=2085735]
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark our homepage.
